|
Volumn 342, Issue , 2011, Pages
|
HIV prevention trial in women is abandoned after drugs show no impact on infection rates.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ORGANOPHOSPHORUS COMPOUND;
DRUG COMBINATION;
EARLY TERMINATION OF CLINICAL TRIAL;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DRUG COMBINATIONS;
EARLY TERMINATION OF CLINICAL TRIALS;
FEMALE;
HIV INFECTIONS;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
|
EID: 79959589508
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.d2613 Document Type: Note |
Times cited : (6)
|
References (0)
|